Amazon invested hundreds of thousands in Nautilus Biotechnology
Andy Jassy, CEO of Amazon and then CEO of Amazon Net Companies, listens during the Amazon Website Companies Summit in San Francisco on April 19, 2017.
David Paul Morris | Bloomberg | Getty Photos
Amazon invested millions in a pre-earnings biotechnology company that went general public just after merging with a specific-goal acquisition company in early June, in accordance to a regulatory submitting introduced very last week.
The shift suits with Amazon’s endeavours to make a presence in well being treatment. The on the internet retailer now operates an on the net pharmacy adhering to the $753 million acquisition of start off-up PillPack in 2018, and in June an Amazon government claimed other businesses are interested in making use of the Amazon Care telehealth support.
Amazon disclosed that it held a $14.7 million stake in Nautilus Biotechnology on June 30. Next the publication of this story on Thursday, shares had
